GLMD Galmed Pharmaceuticals Ltd.
-
Galmed Pharmaceuticals Reported Earnings
Wednesday, July 8, 2026 · 12:00 AM ET
Galmed Pharmaceuticals (GLMD) reported a loss of $0.29 per share on revenue of $0.00 million for the . .
Galmed Pharmaceuticals Ltd. is a clinical-stage biopharmaceutical company. It is focused on developing therapies for liver diseases and gallstones. Galmed Pharmaceuticals Ltd. is based in Tel Aviv, Israel.
Earnings Whisper Grade
—
Power Rating—
Reported Earnings
($0.29)
Earnings Whisper®
—
Consensus Estimate
—
Earnings Surprise
Earnings Growth
Reported Revenue
—
Revenue Estimate
—
Revenue Surprise
Revenue Growth—